Howard Fine, MD
Retina Specialist · New Brunswick, NJNPI 1295810059
Payments from drug & device makers
Across 659 payments — averaging $2575.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$544K
- Bayer$364K
- Genentech, Inc.$341K
- Regeneron Healthcare Solutions, Inc.$259K
- Apellis Pharmaceuticals, Inc.$86K
- Genentech USA, Inc.$34K
- plus $69K from 15 others
Across 4 payments — averaging $86.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$347
What the payments were for
- Consulting fees$40,3184%
- Speaking & faculty fees$877,69692%
- Travel & lodging$28,9293%
- Food & beverage$7,5621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $544,255 |
| Bayer | 255 | $363,567 |
| Genentech, Inc. | 49 | $341,386 |
| Regeneron Healthcare Solutions, Inc. | 199 | $259,306 |
| Apellis Pharmaceuticals, Inc. | 66 | $86,314 |
| Genentech USA, Inc. | 22 | $33,640 |
| Regeneron | 7 | $22,547 |
| Astellas Pharma Global Development | 7 | $14,511 |
| Harrow Eye, LLC | 6 | $11,544 |
| Novartis Pharma AG | 1 | $11,275 |
| AbbVie(2 entities) | 14 | $2,386 |
| Novartis | 4 | $2,367 |
| Neurotech Pharmaceuticals, Inc. | 1 | $2,074 |
| Alimera Sciences, Inc. | 1 | $1,390 |
| Astellas Pharma US Inc | 11 | $327 |
| Bausch & Lomb Americas Inc. | 2 | $39 |
| Samsara Vision | 2 | $38 |
| Notal Vision, Inc. | 1 | $30 |
| Sandoz | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Auris Health, Inc. | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,697,037 in reported general payments places this provider in the 95th percentile of 35 retina specialist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 106 | $5,745 |
| Bromfenac Sodium | 18 | $4,263 |
| Ketorolac Tromethamine | 31 | $980 |
| Latanoprost | 57 | $550 |
| Atropine Sulfate | 13 | $494 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 25 | $365 |
| Timolol Maleate | 41 | $281 |
| Brimonidine Tartrate | 34 | $238 |
| Dorzolamide Hcl | 13 | $209 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in New Brunswick
- Sumit ShahNew Brunswick$714K
- Daniel RothNew Brunswick$361K
- Jonathan PrennerNew Brunswick$215K
- Harold WheatleyNew Brunswick$87K
- Bruce KeyserNew Brunswick$8K
- Eric FriedmanNew Brunswick$554
- Stuart GreenNew Brunswick$22
- Leonard FeinerUnion$781K
- Joshua MaliFlemington$251K
- Mohammedyusuf HajeeToms River$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.